beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology
- PMID: 10681545
- DOI: 10.1074/jbc.275.8.5626
beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology
Abstract
Alzheimer's disease pathology is characterized by the presence of neuritic plaques and the loss of cholinergic neurons in the brain. The underlying mechanisms leading to these events are unclear, but the 42-amino acid beta-amyloid peptide (Abeta(1-42)) is involved. Immunohistochemical studies on human sporadic Alzheimer's disease brains demonstrate that Abeta(1-42) and a neuronal pentameric cation channel, the alpha7 nicotinic acetylcholine receptor (alpha7nAChR), are both present in neuritic plaques and co-localize in individual cortical neurons. Using human brain tissues and cells that overexpress either alpha7nAChR or amyloid precursor protein as the starting material, Abeta(1-42) and alpha7nAChR can be co-immunoprecipitated by the respective specific antibodies, suggesting that they are tightly associated. The formation of the alpha7nAChR.Abeta(1-42) complex can be efficiently suppressed by Abeta(12-28), implying that this Abeta sequence region contains the binding epitope. Receptor binding experiments show that Abeta(1-42) and alpha7nAChR bind with high affinity, and this interaction can be inhibited by alpha7nAChR ligands. Human neuroblastoma cells overexpressing alpha7nAChR are readily killed by Abeta(1-42), whereas alpha7nAChR agonists such as nicotine and epibatidine offered protection. Because Abeta(1-42) inhibits alpha7nAChR-dependent calcium activation and acetylcholine release, two processes critically involved in memory and cognitive functions, and the distribution of alpha7nAChR correlates with neuritic plaques in Alzheimer's disease brains, we propose that interaction of the alpha7nAChR and Abeta(1-42) is a pivotal mechanism involved in the pathophysiology of Alzheimer's disease.
Similar articles
-
Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors.J Neurochem. 2000 Sep;75(3):1155-61. doi: 10.1046/j.1471-4159.2000.0751155.x. J Neurochem. 2000. PMID: 10936198
-
S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies.Biol Psychiatry. 2010 Mar 15;67(6):522-30. doi: 10.1016/j.biopsych.2009.09.031. Epub 2009 Nov 22. Biol Psychiatry. 2010. PMID: 19932469
-
Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.Neuroscience. 2002;110(2):199-211. doi: 10.1016/s0306-4522(01)00460-2. Neuroscience. 2002. PMID: 11958863
-
Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.Curr Pharm Des. 2006;12(6):677-84. doi: 10.2174/138161206775474224. Curr Pharm Des. 2006. PMID: 16472157 Review.
-
Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease.CNS Neurol Disord Drug Targets. 2024;23(3):384-394. doi: 10.2174/1871527322666230627123426. CNS Neurol Disord Drug Targets. 2024. PMID: 37366362 Review.
Cited by
-
Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.J Neurochem. 2016 Sep;138(6):785-805. doi: 10.1111/jnc.13713. Epub 2016 Sep 8. J Neurochem. 2016. PMID: 27333343 Free PMC article. Review.
-
Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease and mild cognitive impairment.Front Immunol. 2022 Sep 23;13:1010946. doi: 10.3389/fimmu.2022.1010946. eCollection 2022. Front Immunol. 2022. PMID: 36211392 Free PMC article. Review.
-
Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.Neuromolecular Med. 2013 Sep;15(3):549-69. doi: 10.1007/s12017-013-8242-1. Epub 2013 Jul 11. Neuromolecular Med. 2013. PMID: 23842742
-
Single-molecule imaging reveals aβ42:aβ40 ratio-dependent oligomer growth on neuronal processes.Biophys J. 2013 Feb 19;104(4):894-903. doi: 10.1016/j.bpj.2012.12.051. Biophys J. 2013. PMID: 23442968 Free PMC article.
-
Aβ1-16 controls synaptic vesicle pools at excitatory synapses via cholinergic modulation of synapsin phosphorylation.Cell Mol Life Sci. 2021 Jun;78(11):4973-4992. doi: 10.1007/s00018-021-03835-5. Epub 2021 Apr 17. Cell Mol Life Sci. 2021. PMID: 33864480 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases